OLD PHARMA confirms its commitment to developing a global network by participating in CPHI & PMEC China 2026, scheduled to take place in Shanghai from 16 to 18 June 2026,…
OLD PHARMA will participate in the 65th AFI Symposium, scheduled for June 10-12, 2026, in Rimini, Italy. This is a key event for the Italian and international pharmaceutical industry. The…
A strategic transaction strengthening its position across the pharmaceutical and chemical pharmaceutical supply chain OLD PHARMA International S.r.l., a company of the Prodotti Gianni S.r.l. Group, announces the acquisition of…
We have already discussed in our previous article the importance of Ceftriaxone and its role as a therapeutic standard. Ceftazidime, which we will address today, should instead be regarded as…
The relevance of ceftriaxone in 2026 has not diminished—quite the opposite. Current challenges linked to antimicrobial resistance and the increasing volatility of global supply chains have further amplified its strategic…
The active role and clinical value of cephalosporins in modern antibiotic therapy, with a focus on supply chain dynamics and future scenarios. What Are Third Generation Cephalosporins? Cephalosporins belong to…
For those involved in the distribution and supply of APIs (Active Pharmaceutical Ingredients), clindamycin is a concrete example of how a well-established drug can continue to generate high-level industrial and…
This Christmas, OLD PHARMA has chosen to support a project that reflects the values it fully embraces: inclusion, respect for the individual and responsibility toward the community. The contribution is…
OLD PHARMA is pleased to announce the achievement of the GDP Good Distribution Practices certification, a result that confirms full compliance with international standards for the distribution of pharmaceutical active…
In recent years, the treatment of retinal diseases has experienced remarkable progress. Conditions that once led to inevitable visual deterioration can now be effectively and durably controlled. Among the key…
A well-established therapeutic profile Lactulose is a synthetic disaccharide derived from lactose and has been widely used in clinical practice for decades. Recognized for its safety and efficacy, it is…
The pharmaceutical industry is undergoing a radical transformation, and at the heart of this evolution lies Artificial Intelligence (AI) and Generative AI (GenAI). Once considered futuristic, these technologies are now…
The CPHI 2024 has now concluded, and we at OLD PHARMA have returned from CPHI Milan 2024 with an extremely positive experience and full of new stimuli. The event, one…
Amikacin is an antibiotic belonging to the aminoglycoside group, known for its efficacy in treating serious infections caused by Gram-negative bacteria. This drug is used in settings where pathogens are…
We are proud to announce that OLD PHARMA has reached an important milestone in its sustainability journey by earning the prestigious “Committed” badge from EcoVadis, one of the world’s leading…
2 Companies, 1 Mission. Old Pharma and Prodotti Gianni together for the first time at CPHI Milano 2024, the international reference event for the pharmaceutical sector that will be held…
Eye health is a vital aspect of overall well-being that is often overlooked until visible or painful problems arise. Of the many conditions that can affect the eye, inflammation is…
In recent years, the scientific community has intensified efforts to combat antibiotic resistance. Among the new therapeutic options, in addition to Pivmecillin which we have already covered in a specific…
In recent years, the issue of drug shortages has become increasingly critical. Disruptions in the supply of essential medicines not only put patients' health at risk, but can also undermine…
In the vast arsenal of antibiotics available to modern medicine, Pivmecillin has occupied an important position since its discovery. Its use has recently sparked heated debates regarding its role in…